Corvex, Inc. MOVE
to the Merger Agreement, as further described below. Following the closing of the Merger, the Company will conduct its operations
through two primary business divisions. Our AI cloud computing business specializes in GPU-accelerated infrastructure for AI workloads
and our healthcare business consists of our wellness ring (formerly referred to as the Evie Ring) (the "Wellness Ring"), a
wearable designed specifically for women that was launched in November 2023.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $433.0K | $1.0M | — | — | — | — | — |
| Cost of revenue | $2.3M | $3.0M | — | — | — | — | — |
| Gross profit | -$1.8M | -$2.0M | — | — | — | — | — |
| R&D | $5.7M | $11.2M | $16.9M | $19.0M | $13.4M | $8.4M | — |
| SG&A | $7.9M | $11.0M | $12.8M | $11.5M | $6.4M | $2.7M | — |
| Total operating expenses | $15.9M | $25.2M | $29.7M | $30.5M | $19.8M | $11.1M | — |
| Operating income | -$15.5M | -$24.2M | -$29.7M | -$30.5M | -$19.8M | -$11.1M | — |
| Interest expense | — | — | — | $133.0K | $883.0K | $1.0M | — |
| Pre-tax income | -$18.3M | — | — | — | — | — | — |
| Net income | -$18.3M | -$23.7M | -$29.3M | -$30.3M | -$21.8M | -$13.0M | — |
| EPS, basic | -21.79 | -39.39 | -9.51 | -0.92 | -0.92 | — | — |
| EPS, diluted | -21.79 | -39.39 | -9.51 | -0.92 | -0.92 | -6.85 | — |
| Shares, diluted (wtd. avg.) | 840,720 | 602,333 | 3.1M | 33.0M | 26.3M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.8M | $7.9M | $6.1M | $10.8M | $17.7M | $5.7M | $4.3M |
| Short-term investments | — | — | — | — | $15.9M | — | — |
| Inventory | $1.8M | $2.0M | $1.1M | — | — | — | — |
| Total current assets | $5.0M | $10.4M | $8.5M | $11.6M | $35.1M | $6.9M | — |
| Property, plant and equipment | $101.0K | $213.0K | $342.0K | $443.0K | $529.0K | $38.0K | — |
| Total assets | $5.6M | $11.3M | $9.4M | $13.2M | $36.3M | $7.1M | — |
| Accounts payable | $3.5M | $2.0M | $3.1M | $557.0K | $311.0K | $246.0K | — |
| Total current liabilities | $8.8M | $3.4M | $5.9M | $5.0M | $3.2M | $1.2M | — |
| Total liabilities | $9.1M | $4.0M | $6.0M | $5.3M | $3.5M | $15.1M | — |
| Retained earnings | -$166.4M | -$148.1M | -$124.4M | -$95.1M | -$64.8M | -$40.9M | — |
| Total equity | -$3.5M | $7.4M | $3.4M | $7.9M | $32.7M | -$40.9M | -$19.9M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$11.3M | -$22.5M | -$26.2M | -$24.9M | -$16.2M | -$10.7M | — |
| Depreciation and amortisation | $149.0K | $166.0K | $158.0K | $147.0K | $74.0K | $13.0K | — |
| Stock-based compensation | $2.9M | $3.2M | $3.0M | $3.1M | $1.9M | $446.0K | — |
| Capital expenditure | — | $8.0K | $64.0K | $105.0K | $565.0K | — | — |
| Investing cash flow | — | -$8.0K | -$64.0K | $15.7M | -$16.7M | — | — |
| Financing cash flow | $6.2M | $24.3M | $21.6M | $2.3M | $44.8M | $12.1M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-048135.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1.0M | $433.0K |
| Gross profit | — | — | — | — | — | -$2.0M | -$1.8M |
| Net income | — | -$13.0M | -$21.8M | -$30.3M | -$29.3M | -$23.7M | -$18.3M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Results announced Item 2.02
- Unregistered share sale Item 3.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event Item 8.01
- Other event Item 8.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7374
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ADP | AUTOMATIC DATA PROCESSING INC | $120.83B | 27.8x | 6.7% |
| WDAY | Workday, Inc. | $51.49B | 81.1x | 13.1% |
| RDDT | Reddit, Inc. | $27.75B | 55.1x | 69.4% |
| VRSK | Verisk Analytics, Inc. | $25.66B | 30.2x | 6.6% |
| TOST | Toast, Inc. | $18.91B | 58.4x | 24.1% |
| HNGE | Hinge Health, Inc. | $8.81B | — | 50.6% |
| RNG | RingCentral, Inc. | $7.01B | 173.7x | 4.8% |
| PEGA | PEGASYSTEMS INC | $5.99B | 17.1x | 16.6% |